We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
A new study finds people with opioid use disorder who are incarcerated and receive the opioid addiction medication buprenorphine are less likely to be rearrested and reconvicted after they are released.
View our curated digest of the latest research news, including the association between the concurrent use of e-cigarettes and cannabis with COVID-19 symptoms, testing and diagnosis among college student e-cigarette users.
A new study finds significant increases in the frequency and severity of emergency department visits due to marijuana exposures in children in Ontario, Canada, after the legalization of recreational marijuana.
Many flavored vaping products continue to be sold despite a federal judge’s ruling that should have led to them being pulled from the market, according to a report by the Campaign for Tobacco-Free Kids.
Harm reduction groups are calling on the Biden administration to make the opioid overdose reversal medication naloxone available to them over-the-counter, NPR reports. Currently, naloxone is a prescription drug. These groups must meet a series of requirements to purchase naloxone from drug companies.
The Substance Abuse and Mental Health Services Administration on Wednesday announced a $30 million harm reduction program to help address the nation’s substance use and overdose epidemic, Newsweek reports.